Not Yet RecruitingNot Applicable

Cervical TsDCS on Stroke Patients

Italy40 participantsStarted 2025-03

Plain-language summary

The present project aims to evaluate the facilitatory modulation of motor responses of the limb upper limb by tsDCS in patients with arm/hand hyposthenia after cerebral ischemia to verify the possible therapeutic benefits that this type of stimulation can induce in terms of of strength, dexterity and effectiveness in acts of daily living.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. age over 18 years;
✓. first ischemic/hemorrhagic stroke (within 30 days of onset);
✓. mild-to-moderate stroke (NIHSS scale score\<16).
✓. residual function of the upper limb, assessed by the following scales: - MRC of the distal muscles of the upper limb: score between 2 and 4; - NHISS (items 5A and 5B): score between 1 and 3;
✓. ability to give informed consent and understand instructions.

Exclusion criteria

✕. severe spasticity (Ashworth Scale score \> 2);
✕. severe aphasia;
✕. severe neglect;
✕. history of disabling neurological disease;
✕. history of epilepsy;
✕. significant comorbidities;
✕. contraindications to tsDCS.
✕. age over 18 years;

What they're measuring

improvement of paretic hand performance

Timeframe: through study completion, an average of 1 year

improvement of paretic hand performance

Timeframe: through study completion, an average of 1 year

improvement of paretic hand performance

Timeframe: through study completion, an average of 1 year

improvement of paretic hand performance

Timeframe: through study completion, an average of 1 year

improvement of paretic hand performance

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT06826274

SponsorIRCCS San Raffaele Roma

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01

Contact for this trial

Fabrizio Vecchio

3478031201 fabrizio.vecchio@sanraffaele.it

View on ClinicalTrials.gov More Functional Recovery trials

Plain-language summary

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. age over 18 years;
✓. first ischemic/hemorrhagic stroke (within 30 days of onset);
✓. mild-to-moderate stroke (NIHSS scale score\<16).
✓. residual function of the upper limb, assessed by the following scales: - MRC of the distal muscles of the upper limb: score between 2 and 4; - NHISS (items 5A and 5B): score between 1 and 3;
✓. ability to give informed consent and understand instructions.

Exclusion criteria

✕. severe spasticity (Ashworth Scale score \> 2);
✕. severe aphasia;
✕. severe neglect;
✕. history of disabling neurological disease;
✕. history of epilepsy;
✕. significant comorbidities;
✕. contraindications to tsDCS.
✕. age over 18 years;

What they're measuring

improvement of paretic hand performance

Timeframe: through study completion, an average of 1 year

improvement of paretic hand performance

Timeframe: through study completion, an average of 1 year

improvement of paretic hand performance

Timeframe: through study completion, an average of 1 year

improvement of paretic hand performance

Timeframe: through study completion, an average of 1 year

improvement of paretic hand performance

Timeframe: through study completion, an average of 1 year